Itraconazol Cf

Itraconazole, the active ingredient in Itraconazol Cf, is an azole antifungal presented as an oral formulation for oral use. It treats systemic mycoses, dermatophytosis, onychomycosis and candidiasis in adult patients. GNH USA supplies Itraconazol Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Itraconazole is used to treat fungal infections that affect various organ systems and skin structures. - Systemic mycoses: effective against histoplasmosis, blastomycosis and coccidioidomycosis, reducing fungal burden and preventing disease progression. - Dermatophytosis and onychomycosis: clears skin and nail infections caused by dermatophytes, improving appearance and symptoms. - Candidiasis: treats oral, esophageal and systemic Candida infections, relieving discomfort and preventing dissemination.

Itraconazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort in the abdomen. - Diarrhea: loose stools occurring during therapy. - Rash: mild skin redness or itching. - Elevated liver enzymes: mild, reversible changes in liver function tests.

Serious or Rare Side Effects: - Hepatotoxicity: significant liver injury requiring monitoring. - Congestive heart failure: worsening of pre‑existing cardiac conditions. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Visual disturbances: blurred vision or photopsia. - Peripheral edema: swelling of extremities. - Anaphylaxis: rare but life‑threatening allergic reaction.

Before initiating itraconazole therapy, consider the following safety measures. - Liver function: assess baseline hepatic enzymes and monitor periodically. - Cardiac status: avoid in patients with existing heart failure. - Drug interactions: review concomitant medications for potential CYP3A4 interactions. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Renal impairment: adjust dosing only under medical supervision. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Itraconazole interacts with several drug classes; careful management is required.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): markedly reduce itraconazole exposure. - Certain antiarrhythmics (e.g., quinidine, amiodarone): increase risk of cardiac toxicity. - HIV protease inhibitors (e.g., ritonavir): may cause dangerous plasma level elevations.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin, lovastatin): increased risk of myopathy. - Benzodiazepines (e.g., midazolam, triazolam): enhanced sedative effects. - Calcium channel blockers (e.g., verapamil): possible increased plasma concentrations. - Oral contraceptives: reduced efficacy, consider alternative contraception.